PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, 605 SAF Building, South Kensington Campus, London CB4 0FZ, U.K.\', \'Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge SW7 2AZ, U.K.\', \'Safety, Health and Environment (SHE), Cambridge Operations, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.\', \'Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB22 3AT, U.K.\', \'Translational Medicine, Oncology R&D, AstraZeneca, Cambridge SG8 6EH, U.K.\', \'Bioscience, Discovery, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, U.K.\', \'National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI), National Physical Laboratory, Teddington TW11 0LW, U.K.\', \'Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acs.analchem.0c03430
?:hasPublicationType
?:journal
  • Analytical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 33474935
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.362
?:rankingScore_hIndex
  • 295
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of UV-C Decontamination of Clinical Tissue Sections for Spatially Resolved Analysis by Mass Spectrometry Imaging (MSI).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all